Concepedia
11
Publications
320
Citations
H-Index
2011
Active since
Affiliations
Novo Nordisk (Denmark)(Current)
AMCR Institute
Institut für Klinische Forschung und Entwicklung
Institute of Public Health Zadar
Novo Nordisk (United Kingdom)
Marcus Niemeyer is an author at Novo Nordisk (Denmark) specializing in diabetes, medicine, and metabolic syndrome.
Top concepts
DiabetesMedicineHealthInsulin ResistanceMetabolic Syndrome
Publications per year
2011–2016
Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)
Athena Philis‐Tsimikas, Meryl Brod, Marcus Niemeyer et al. · Advances in Therapy · 2013 · 51 citations · Full text
Diabetes Management, Insulin Management, Diabetes +6
Comparison of Patient Preference for Two Insulin Injection Pen Devices in Relation to Patient Dexterity Skills
Andreas Pfützner, Christina Schipper, Marcus Niemeyer et al. · Journal of Diabetes Science and Technology · 2012 · 37 citations · Full text
Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial
Ajay Kumar, Edward Franek, Jonathan Wise et al. · PLoS ONE · 2016 · 37 citations · Full text
Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals
Andreas Pfützner, Timothy S. Bailey, Carlos Campos et al. · Current Medical Research and Opinion · 2013 · 34 citations
Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses
David S. Oyer, Parth Narendran, Marianne Qvist et al. · Expert Opinion on Drug Delivery · 2011 · 28 citations
Rows per page
1–5 of 11